Ryzodeg FlexTouch

Ryzodeg FlexTouch Description


Novo Nordisk


Full Prescribing Info
1 ml solution contains 100 units insulin degludec/insulin aspart* in the ratio 70/30 (equivalent to 2.56 mg insulin degludec and 1.05 mg insulin aspart).
One pre-filled pen contains 300 units of insulin degludec/insulin aspart in 3 ml solution.
*Produced in Saccharomyces cerevisiae by recombinant DNA technology.
Excipients/Inactive Ingredients: Glycerol, metacresol, phenol, sodium chloride, zinc acetate, hydrochloric acid/sodium hydroxide (for pH adjustment) and water for injections.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in